China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Xi to attend APEC meeting, visit ROK from Oct 30 to Nov 1
- Fight against corruption a protracted battle with no finish line, official says
- Experts and scholars propose strategies for advancing cross-Strait ties
- China prepares to launch Shenzhou XXI crewed spaceship
- China to strengthen the development of AI technologies
- Scientific, technological modernization emphasized in promoting China's advancement
